Chen Z, Vallega KA, Wang D, Quan Z, et al. DNA topoisomerase II inhibition potentiates osimertinib's therapeutic efficacy in EGFR-mutant non-small cell lung cancer models. J Clin Invest 2024 Mar 7:e172716. doi: 10.1172/JCI172716.
PMID: 38451729